3 insider filings
Jay S Stout, insider filing for IMVT
Show all 3
- 4Insider filing for IMVT
- 4Insider filing for IMVT
- 4Insider filing for IMVT
Jay S Stout, reporting
Every EDGAR filing for Immunovant, Inc. (IMVT), newest first, with AI summaries and stories.
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
No open-market insider buys in the last 30 days.
Also: 6 open-market sales ($460K), 1 grant or exercise.
Jay S Stout, insider filing for IMVT
Jay S Stout, reporting
Eric Venker
Tuyl Christopher Van, insider filing for IMVT
Tuyl Christopher Van, reporting
Atul Pande, insider filing for IMVT
Atul Pande, reporting
Melanie Gloria, insider filing for IMVT
Melanie Gloria, reporting
Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
Atul Pande, insider filing for IMVT
Atul Pande, reporting
Melanie Gloria, insider filing for IMVT
Melanie Gloria, reporting
Eric Venker, insider filing for IMVT
Eric Venker, reporting
Melanie Gloria, insider filing for IMVT
Melanie Gloria, reporting
Jay S Stout, planned sale of IMVT shares
Jay S Stout, reporting
Tuyl Christopher Van, insider filing for IMVT
Tuyl Christopher Van, reporting
Atul Pande, insider filing for IMVT
Atul Pande, reporting
Atul Pande, planned sale of IMVT shares
Atul Pande, reporting
Andrew J. Fromkin, insider filing for IMVT
Andrew J. Fromkin, reporting
Andrew J. Fromkin, planned sale of IMVT shares
Andrew J. Fromkin, reporting
Melanie Gloria, insider filing for IMVT
Melanie Gloria, reporting
Atul Pande, insider filing for IMVT
Atul Pande, reporting
Atul Pande, planned sale of IMVT shares
Atul Pande, reporting
Robert Graham Susman, insider filing for IMVT
Robert Graham Susman, reporting
Robert Graham Susman, planned sale of IMVT shares
Robert Graham Susman, reporting
Tiago Girao, insider filing for IMVT
Tiago Girao, reporting
Tuyl Christopher Van, insider filing for IMVT
Tuyl Christopher Van, reporting
Frank Torti, insider filing for IMVT
Frank Torti, reporting